Troxerutin suppresses the stemness of osteosarcoma via the CD155/SRC/β-catenin signaling axis

Abstract Background Osteosarcoma is the most prevalent primary malignant bone tumor affecting pediatric and adolescent individuals. However, despite the passage of three decades, there has been no notable enhancement in the overall survival rate of patients with osteosarcoma. In recent years, CD155...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Junkai Chen, Hongbo Li, Qinglin Jin, Xiaoguang Li, Yiwen Zhang, Jingnan Shen, Gang Huang, Junqiang Yin, Changye Zou, Xinyu Li, Xin He, Xianbiao Xie, Tiao Lin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-04-01
Edice:	Cellular & Molecular Biology Letters
Témata:	CD155 Osteosarcoma β-catenin Stemness Troxerutin
On-line přístup:	https://doi.org/10.1186/s11658-025-00724-8
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!